rs1202306773
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PP3_StrongPP5
The NM_001875.5(CPS1):c.4232C>T(p.Pro1411Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000131 in 1,450,936 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001875.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CPS1 | NM_001875.5 | c.4232C>T | p.Pro1411Leu | missense_variant | Exon 36 of 38 | ENST00000233072.10 | NP_001866.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251198Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135770
GnomAD4 exome AF: 0.0000131 AC: 19AN: 1450936Hom.: 0 Cov.: 28 AF XY: 0.0000152 AC XY: 11AN XY: 722684
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Pulmonary hypertension, neonatal, susceptibility to Pathogenic:1
- -
not specified Uncertain:1
Variant summary: CPS1 c.4232C>T (p.Pro1411Leu) results in a non-conservative amino acid change located in the methylglyoxal synthase-like domain (IPR011607) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251198 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.4232C>T has been reported in the literature as a biallelic genotype in two individuals affected with late-onset Carbamoylphosphate Synthetase I Deficiency (Summar_1998, Eeds_2006). These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function and found the variant results in approximately 50% of normal activity (Pekkala_2010). The following publications have been ascertained in the context of this evaluation (PMID: 16737834, 20578160, 9686343). One submitter has provided a clinical-significance assessment for this variant to ClinVar after 2014 and has classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -
Congenital hyperammonemia, type I Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at